Letters to HCPs

Important information for Healthcare Professionals

Pre-treatment testing to identify DPD-deficient patients at increased risk of severe and fatal toxicity

Direct Healthcare Professional Communication regarding 5-Fluorouracil (i.v.), Capecitabine and Tegafur containing products - Pre-treatment testing to identify DPD-deficient patients at increased risk of severe and fatal toxicity

For Healthcare Professionals